Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
15.72
-0.12 (-0.76%)
At close: Jun 24, 2026, 4:00 PM EDT
15.80
+0.08 (0.48%)
After-hours: Jun 24, 2026, 7:17 PM EDT
Takeda Pharmaceutical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Takeda Pharmaceutical stock has a consensus rating of "Strong Buy" and an average price target of $20.63. The average 1-year stock price forecast is 31.23% higher than the current stock price, while the lowest is $19.26 (+22.52%) and the highest is $21.82 (+38.80%).
Price Target: $20.63 (+31.23%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Takeda Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $21 | Buy | Maintains | $21 | +33.59% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
4.63T
from 4.51T
Increased by 2.76%
Revenue Next Year
4.70T
from 4.63T
Increased by 1.52%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 4.7T | ||
| Avg | 4.6T | ||
| Low | 4.5T |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 5.3% | ||
| Avg | 2.8% | ||
| Low | -0.4% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2028 | 2029 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |